Data supporting “The effect of current helminth infection on vaccine responses among adolescents living in helminth-endemic islands of Lake Victoria, Uganda”

The data contain anonymized individual-level records of 478 schoolchildren (aged 9-17 years) who participated in a randomized controlled trial investigating the effect of Schistosomiasis treatment on responses to a portfolio of vaccines, known as the POPVAC A trial. Helminth infections were assessed prior to vaccination to enable comparisons of vaccine-specific immune responses between infected and uninfected children, aiming to answer the question of whether helminth infection before vaccination affects responses observed following vaccination.